|1.||Su, Chen: 1 article (11/2014)|
|2.||Le, Alexander M: 1 article (11/2014)|
|3.||Wang, Jing: 1 article (11/2014)|
|4.||Zou, Anthony: 1 article (11/2014)|
|5.||Lee, Michelle: 1 article (11/2014)|
|6.||Ren, Jun: 1 article (12/2006)|
|7.||Greer, John J: 1 article (12/2006)|
|8.||Funk, Gregory D: 1 article (12/2006)|
|9.||Poon, Betty Y: 1 article (12/2006)|
|10.||Tang, Yun: 1 article (12/2006)|
|1.||Respiratory Insufficiency (Respiratory Failure)
12/15/2006 - "CX546 effectively reverses opioid- and barbiturate-induced respiratory depression without reversing the analgesic response. "
12/15/2006 - "We determined whether the ampakine CX546 would enhance respiratory drive and rhythmogenesis across various stages of development and whether this ampakine could counter opioid- and barbiturate-induced respiratory depression. "
11/01/2014 - "They found that CX546, compared with control, also reduced depressive symptoms of pain by decreasing immobility on the forced swim test in both SNI (both DMSO and CX546 groups, n = 8) and CFA models (both DMSO and CX546 groups, n = 10). "
11/01/2014 - "The authors studied AMPAkines (CX546 and CX516) in rat spared nerve injury (SNI) model of neuropathic pain and Complete Freund's Adjuvant (CFA) model of inflammatory pain. "
|3.||Neuralgia (Stump Neuralgia)
|2.||Dimethyl Sulfoxide (DMSO)
|4.||barbituric acid (barbiturate)